Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kumi, Horii"'
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Maki Konishi, Junko S. Takeuchi, Kumi Horii, Mitsuru Ozeki, Haruhito Sugiyama, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Publikováno v:
BMC Infectious Diseases, Vol 23, Iss 1, Pp 1-10 (2023)
Abstract Background Longitudinal data are lacking to compare booster effects of Delta breakthrough infection versus third vaccine dose on neutralizing antibodies (NAb) against Omicron. Methods Participants were the staff of a national research and me
Externí odkaz:
https://doaj.org/article/d0605f87e451440196f540c6a5afcbf1
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Publikováno v:
International Journal of Infectious Diseases, Vol 128, Iss , Pp 347-354 (2023)
Objectives: To investigate the role of immunogenicity after the third vaccine dose against Omicron infection and COVID-19-compatible symptoms of infection. Methods: First, we examined vaccine effectiveness (VE) of the third dose against the second do
Externí odkaz:
https://doaj.org/article/fec3573d884a494d9dd25717a6e815d2
Autor:
Kohei Kamegai, Noriko Iwamoto, Masahiro Ishikane, Kei Yamamoto, Kumi Horii, Shiho Kubota, Akira Hangaishi, Hiroshi Shimazu, Tomiteru Togano, Hiroyuki Yamashita, Yasuhide Yamada, Norio Ohmagari
Publikováno v:
Global Health & Medicine; Dec2023, Vol. 5 Issue 6, p366-371, 6p
Autor:
Shohei Yamamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Kumi Horii, Kaori Okudera, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Wataru Sugiura, Norio Ohmagari
Publikováno v:
Clinical Microbiology and Infection.
BackgroundEpidemiological data regarding differences in durability and its determinants of humoral immunity following 2- and 3-dose COVID-19 vaccination are scarce.MethodsWe repeatedly assessed the anti-spike IgG antibody titers of 2- and 3-dose mRNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9025e9f437877cf43b0c3f179f8cfc2d
https://doi.org/10.1016/j.cmi.2023.05.020
https://doi.org/10.1016/j.cmi.2023.05.020
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Junko S. Takeuchi, Yunfei Li, Maki Konishi, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Shinichi Oka, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
ImportanceInvestigating the role of pre-infection humoral immunity against Omicron BA.5 infection risk and long COVID development is critical to inform public health guidance.ObjectiveTo investigate the association between pre-infection immunogenicit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10c57d8f3ba834f49178db614c6cc661
https://doi.org/10.1101/2023.04.05.23288162
https://doi.org/10.1101/2023.04.05.23288162
Autor:
Tetsuya Mizoue, Shohei Yamamoto, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Kumi Horii, Kaori Okudera, Maki Konishi, Mitsuru Ozeki, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Wataru Sugiura, Norio Ohmagari
Publikováno v:
Epidemiology and Infection. 151
To describe the trend of cumulative incidence of coronavirus disease 19 (COVID-19) and undiagnosed cases over the pandemic through the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants among healthcare workers in Toky
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::92a15870a9e4123b57b471a13ddfc737
https://doi.org/10.1017/s0950268823000353
https://doi.org/10.1017/s0950268823000353
Autor:
Shohei Yamamoto, Kenji Maeda, Kouki Matsuda, Akihito Tanaka, Kumi Horii, Kaori Okudera, Junko S Takeuchi, Tetsuya Mizoue, Maki Konishi, Mitsuru Ozeki, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
Background While increasing coverage of effective vaccines against coronavirus disease 2019 (COVID-19), emergent variants raise concerns about breakthrough infection. Data are limited, however, whether breakthrough infection during the epidemic of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ec6e3726ab357c25ac6efe1aed2519
https://doi.org/10.1093/cid/ciab1048
https://doi.org/10.1093/cid/ciab1048
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Kumi Horii, Kaori Okudera, Yusuke Oshiro, Natsumi Inamura, Junko S. Takeuchi, Maki Konishi, Mitsuru Ozeki, Tetsuya Mizoue, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
BackgroundData on the role of immunogenicity following the third vaccine dose against Omicron infection and coronavirus disease 2019 (COVID-19)-compatible symptoms of infection are limited.MethodsFirst we examined vaccine effectiveness (VE) of the th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::140f3f76b779a7af27205c6e0ea88079
https://doi.org/10.1101/2022.09.15.22280009
https://doi.org/10.1101/2022.09.15.22280009
Autor:
Tetsuya Mizoue, Shohei Yamamoto, Maki Konishi, Yusuke Oshiro, Natsumi Inamura, Takashi Nemoto, Mitsuru Ozeki, Kumi Horii, Kaori Okudera, Haruhito Sugiyama, Nobuyoshi Aoyanagi, Wataru Sugiura, Norio Ohmagari
Publikováno v:
The Journal of infection. 85(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3657ca678b9e5f712456b2be6aa3189
https://pubmed.ncbi.nlm.nih.gov/35995310
https://pubmed.ncbi.nlm.nih.gov/35995310
Autor:
Shohei Yamamoto, Kouki Matsuda, Kenji Maeda, Yusuke Oshiro, Natsumi Inamura, Tetsuya Mizoue, Maki Konishi, Junko S. Takeuchi, Kumi Horii, Mitsuru Ozeki, Haruhito Sugiyama, Hiroaki Mitsuya, Wataru Sugiura, Norio Ohmagari
BackgroundLongitudinal data are lacking to compare booster effects of Delta breakthrough infection versus the third vaccine dose on neutralizing antibodies (NAb) against Omicron.MethodsParticipants were the staff of a national research and medical in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d928879ed986fb1930fd68b4496db923
https://doi.org/10.1101/2022.06.21.22276682
https://doi.org/10.1101/2022.06.21.22276682